Приказ основних података о документу

dc.creatorSopić, Miron
dc.creatorŠupljeglav, Branislava
dc.creatorMilojević, Ana
dc.creatorMihajlović, Marija
dc.creatorNinić, Ana
dc.creatorMunjas, Jelena
dc.creatorGardijan, Vera
dc.creatorRadosavljević, Vojislav
dc.creatorMemon, Lidija
dc.creatorZdravković, Marija
dc.creatorSpasojević-Kalimanovska, Vesna
dc.date.accessioned2024-04-03T14:25:45Z
dc.date.available2024-04-03T14:25:45Z
dc.date.issued2020
dc.identifier.issn0021-9150
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5586
dc.description.abstractBackground and Aims: Obstructive sleep apnea (OSA) is associated with increased risk of cardiovascular disease. Resistin is recognized as a potent proinflammatory cytokine that is able to influence atherosclerotic plaque progression through several mechanisms. ...sr
dc.language.isoensr
dc.publisherElseviersr
dc.rightsrestrictedAccesssr
dc.sourceAtherosclerosissr
dc.titleIncreased gene expression of resistin and CD36 in peripheral blood mononuclear cells is associated with hypercholesterolemia in patients with obstructive sleep apneasr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.citation.volume315
dc.citation.spagee48
dc.citation.epagee49
dc.identifier.wos000748958900132
dc.identifier.doi10.1016/j.atherosclerosis.2020.10.150
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу